Results 171 to 180 of about 18,483 (234)

Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis. [PDF]

BMC Pulm Med
Qi W, Li Z, Xu J, Wang T.
europepmc   +1 more source

CNS penetrant TEAD1,2,4 inhibitor MSC-4070 derived from phenotypic screening hit optimization. [PDF]

RSC Med Chem
Heinrich T, Petersson C, Gunera J, Gambardella A, Schwarz D, Garg S, Schilke H, Weitzel T, Kolb C, Anlauf U, Reither V, Rettig C, Opelt B, Delp A, Wildner N, Sousa PMF, Freire F, Bandeiras TM, Wienke D.   +18 more
europepmc   +1 more source

An Application of Markov-switching Model to stock Returns Analysis [PDF]

Monika Kosko
core  

The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value. [PDF]

World J Urol
Pan JF, Chen YZ, Wang SY, Zhao ZY, Ren DW, Su R, Jia XL, Jiang JH, Ma Q.   +8 more
europepmc   +1 more source

Diagnostic Value of FPSAD and PI-RADS v2.1 for Clinically Significant Prostate Cancer in Patients with tPSA Levels of 4-10 ng/mL. [PDF]

Cancer Manag Res
Guo W, Tan P, He Y, Yi X.
europepmc   +1 more source

Case Report: High-volume, aggressive prostate cancer with borderline psa levels diagnosed by PSMA PET/CT-based comprehensive radiographic scheme and cognitive fusion targeted biopsy. [PDF]

Front Oncol
Zhou Y, Qiu R, Dou M, Bi W, Yu Y.
europepmc   +1 more source

Phyllodes-predominant prostatic stromal sarcoma concurrent with prostate adenocarcinoma: a case report and literature review. [PDF]

Front Oncol
Lian H, Feng W, Zhang M, Tian Y, Wu W, Cui J, Wang Y.   +6 more
europepmc   +1 more source

Multimodal urinary biomarker panel achieves superior prostate cancer detection accuracy and reduces unnecessary biopsies. [PDF]

Transl Oncol
Panahi Y, Avci CB, Ghafarlu A, Nourazarian A.   +3 more
europepmc   +1 more source

The diagnostic value of prostate health index combined with soluble e-cadherin for prostate cancer. [PDF]

Front Endocrinol (Lausanne)
Ahamed Y, Hossain M, Baral S, Chen J, Sun W.   +4 more
europepmc   +1 more source